Quality control limits for fluconazole disk susceptibility tests on Mueller-Hinton agar with glucose and methylene blue

Journal of Clinical Microbiology

Volumn 41, Issue 7, 2003, Pages 3410-3412

  Barry, A ^a   Bille, J ^b   Brown, S ^a   Ellis, D ^c   Meis, J ^d   Pfaller, M ^e   Rennie, R ^f   Rinaldi, M ^g   Rogers, T ^h   Traczewski, M ^a  

^a CLINICAL MICROBIOLOGY INSTITUTE   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^d CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^e UNIVERSITY OF IOWA   (United States)

^f UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; FLUCONAZOLE; GLUCOSE; METHYLENE BLUE;

ANTIBIOTIC RESISTANCE; ARTICLE; CANDIDA PARAPSILOSIS; CONTROLLED STUDY; CULTURE MEDIUM; DIAGNOSTIC ACCURACY; FUNGAL DETECTION; FUNGAL STRAIN; FUNGUS CULTURE; GOOD LABORATORY PRACTICE; IN VITRO STUDY; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; REPRODUCIBILITY; VALIDATION PROCESS;

AGAR; ANTIFUNGAL AGENTS; CANDIDA; CANDIDA ALBICANS; CULTURE MEDIA; FLUCONAZOLE; GLUCOSE; HUMANS; INTERNATIONAL COOPERATION; LABORATORIES; METHYLENE BLUE; MICROBIAL SENSITIVITY TESTS; QUALITY CONTROL;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CANDIDA TROPICALIS; FUNGI;

EID: 0037818322     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.7.3410-3412.2003     Document Type: Article

References (9)

1. Barry, A. L., and S. D. Brown. 1996. Fluconazole disk diffusion procedure for determining susceptibility of Candida species. J. Clin. Microbiol. 34:2154-2157.
2. Barry, A. L., M. A. Pfaller, R. P. Rennie, P. C. Fuchs, and S. D. Brown. 2002. Precision and accuracy of fluconazole susceptibility testing by broth microdilution, E test, and disk diffusion methods. Antimicrob. Agents Chemother. 46:1781-1784.
3. Bille, J. 1997. When should Candida isolates be tested for susceptibility to azole antifungal agents? Eur. J. Clin. Microbiol. Infect. Dis. 16:281-282.
4. Fan-Harvard, P., D. Capano, S. M. Smith, A. Mangia, and R. H. K. Eng. 1991. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob. Agents Chemother. 35:2302-2305.
5. Gavan, T. L., R. N. Jones, A. L. Barry, P. C. Fuchs, E. H. Gerlach, J. M. Matsen, L. B. Reller, C. Thornsberry, and L. D. Thrupp. 1981. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J. Clin. Microbiol. 14:67-72.
6. Kirkpatrick, W. R., T. M. Turner, A. W. Fothergill, D. J. McCarthy, S. W. Redding, M. G. Rinaldi, and T. F. Patterson. 1998. Fluconazole disk diffusion susceptibility testing of Candida species. J. Clin. Microbiol. 36:3429-3432.
7. May, J. L., A. King, and C. A. Warren. 1997. Fluconazole disc diffusion testing for the routine laboratory. J. Antimicrob. Chemother. 40:511-516.
8. Meis, J., M. Petrou, J. Bille, D. Ellis, D. Gibbs, and The Global Antifungal Surveillance Group. 2000. A global evaluation of the susceptibility of Candida species to fluconazole by disk diffusion. Diagn. Microbiol. Infect. Dis. 36:215-223.
9. Sandven, P. 1999. Detection of fluconazole-resistant Candida strains by a disc screening test. J. Clin. Microbiol. 27:3856-3859.